Germany's Bayer makes offer for Norway's Algeta

BERLIN (AP) — Norway-based cancer drug maker Algeta ASA says it has received a preliminary takeover offer from Germany's Bayer AG that values the company at about $2.4 billion.

Algeta said in a statement Tuesday that the offer is for 336 kroner ($55.11) per share; the company has nearly 44 million shares. It said that discussions are at an early stage and the proposal "may or may not lead to a transaction."

Algeta's shares were up 30.3 percent in Oslo at 344.80 kroner after the announcement. Bayer's stock slipped 0.1 percent to 95.93 euros ($129.78) in Frankfurt trading. Algeta has its headquarters in Oslo and has a U.S. subsidiary, Algeta US, LLC, based in Cambridge, Massachusetts.

Related Headlines

  • Norwegian police try to identify amnesia man

    Police in Norway are trying to identify a man who understands five languages but claims he cannot remember his own name or where he comes from. Oslo police on Tuesday ... 

  • Joe Kaesar, Ralf P. Thomas

    Siemens shares rise on buyback announcement

    German industrial conglomerate Siemens said Thursday its profit dropped in the fourth quarter, but its shares rose after it announced it would buy back 4 billion euros ($5.